Movatterモバイル変換

[0]ホーム
URL:

AU2003904627A0 - Pharmaceutical Formulation - Google Patents

Pharmaceutical Formulation

Info

Publication number
AU2003904627A0
AU2003904627A0AU2003904627AAU2003904627AAU2003904627A0AU 2003904627 A0AU2003904627 A0AU 2003904627A0AU 2003904627 AAU2003904627 AAU 2003904627AAU 2003904627 AAU2003904627 AAU 2003904627AAU 2003904627 A0AU2003904627 A0AU 2003904627A0
Authority
AU
Australia
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003904627A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayne Pharma Pty Ltd
Original Assignee
Mayne Pharma Pty Ltd
Filing date
Publication date
Application filed by Mayne Pharma Pty LtdfiledCriticalMayne Pharma Pty Ltd
Publication of AU2003904627A0publicationCriticalpatent/AU2003904627A0/en
Priority to NZ545591ApriorityCriticalpatent/NZ545591A/en
Priority to US10/927,279prioritypatent/US20050090544A1/en
Priority to EP04761205Aprioritypatent/EP1680103A4/en
Priority to CN2010105437134Aprioritypatent/CN102048723A/en
Priority to JP2006524178Aprioritypatent/JP2007504098A/en
Priority to CA002537170Aprioritypatent/CA2537170A1/en
Priority to GB0606187Aprioritypatent/GB2421911A/en
Priority to EP10006355Aprioritypatent/EP2243480A1/en
Priority to PCT/AU2004/001168prioritypatent/WO2005020980A1/en
Priority to CNA2004800320201Aprioritypatent/CN101022790A/en
Priority to AU2004267877Aprioritypatent/AU2004267877A1/en
Priority to GB0718274Aprioritypatent/GB2441445B/en
Priority to DE112004001563Tprioritypatent/DE112004001563T5/en
Priority to CN200910212102Aprioritypatent/CN101703467A/en
Priority to US11/363,542prioritypatent/US20060264501A1/en
Priority to NO20061417Aprioritypatent/NO20061417L/en
Priority to US11/627,648prioritypatent/US20070155833A1/en
Priority to JP2008120644Aprioritypatent/JP2008201804A/en
Priority to HK08106611.8Aprioritypatent/HK1111894B/en
Priority to US12/581,624prioritypatent/US20100035982A1/en
Priority to US12/581,514prioritypatent/US20100063145A1/en
Priority to JP2012003953Aprioritypatent/JP2012072191A/en
Priority to JP2014000261Aprioritypatent/JP2014080426A/en
Priority to JP2015139485Aprioritypatent/JP6078593B6/en
Abandonedlegal-statusCriticalCurrent

Links

AU2003904627A2003-08-282003-08-28Pharmaceutical FormulationAbandonedAU2003904627A0 (en)

Priority Applications (24)

Application NumberPriority DateFiling DateTitle
CN200910212102ACN101703467A (en)2003-08-282004-08-27Acid containing oxaliplatin formulations
AU2004267877AAU2004267877A1 (en)2003-08-282004-08-27Acid containing oxaliplatin formulations
DE112004001563TDE112004001563T5 (en)2003-08-282004-08-27 Acid-containing oxaliplatin formulations
EP04761205AEP1680103A4 (en)2003-08-282004-08-27Acid containing oxaliplatin formulations
CN2010105437134ACN102048723A (en)2003-08-282004-08-27Acid containing oxaliplatin formulations
JP2006524178AJP2007504098A (en)2003-08-282004-08-27 Oxaliplatin formulation containing acid
CA002537170ACA2537170A1 (en)2003-08-282004-08-27Acid containing oxaliplatin formulations
GB0606187AGB2421911A (en)2003-08-282004-08-27Acid containing oxaliplatin formulations
EP10006355AEP2243480A1 (en)2003-08-282004-08-27Pharmaceutical formulations comprising oxaliplatin and an acid.
PCT/AU2004/001168WO2005020980A1 (en)2003-08-282004-08-27Acid containing oxaliplatin formulations
US10/927,279US20050090544A1 (en)2003-08-282004-08-27Oxaliplatin formulations
NZ545591ANZ545591A (en)2003-08-282004-08-27Acid containing oxaliplatin formulations
GB0718274AGB2441445B (en)2003-08-282004-08-27Acid containing oxaliplatin formulation
CNA2004800320201ACN101022790A (en)2003-08-282004-08-27 Oxaliplatin preparations containing acid
US11/363,542US20060264501A1 (en)2003-08-282006-02-28Acid containing oxaliplatin formulations
NO20061417ANO20061417L (en)2003-08-282006-03-28 Acid-containing oxaliplatin formulations
US11/627,648US20070155833A1 (en)2003-08-282007-01-26Oxaliplatin formulations
JP2008120644AJP2008201804A (en)2003-08-282008-05-02Acid-containing oxaliplatin preparation
HK08106611.8AHK1111894B (en)2003-08-282008-06-16Acid containing oxaliplatin formulations
US12/581,514US20100063145A1 (en)2003-08-282009-10-19Acid containing oxaliplatin formulations
US12/581,624US20100035982A1 (en)2003-08-282009-10-19Oxaliplatin formulations
JP2012003953AJP2012072191A (en)2003-08-282012-01-12Acid containing oxaliplatin formulation
JP2014000261AJP2014080426A (en)2003-08-282014-01-06Acid-containing oxaliplatin formulations
JP2015139485AJP6078593B6 (en)2003-08-282015-07-13 Oxaliplatin formulation containing acid

Publications (1)

Publication NumberPublication Date
AU2003904627A0true AU2003904627A0 (en)2003-09-11

Family

ID=

Similar Documents

PublicationPublication DateTitle
EP2289512B8 (en)Pharmaceutical foam
AU2003291103A1 (en)Pharmaceutical composition
AU2003901813A0 (en)Pharmaceutical derivatives
AU2002257582A1 (en)Pharmaceutical formulation
AU2003250372A1 (en)Pharmaceutical composition
AU2002364468A1 (en)Solid orally-dispersible pharmaceutical formulation
HUP0303948A2 (en)Solid orally-dispersible pharmaceutical formulation
AU2003226487A1 (en)Formulation
GB0316206D0 (en)Pharmaceutical formulation
AU2003280387A1 (en)Pharmaceutical formulation comprising azithrocycin monohydrate
AU2003291642A1 (en)Pyrazoloazepine compounds as pharmaceutical agents
AU2003216503A1 (en)Stable pharmaceutical compositions
AU2003238900A1 (en)Pharmaceutical formulation
AU2003904627A0 (en)Pharmaceutical Formulation
AUPS188302A0 (en)Pharmaceutical composition
GB0310881D0 (en)Pharmaceutical formulation
AU2002950788A0 (en)Pharmaceutical formulation
HK1093421A (en)Pharmaceutical formulations
AU2004902190A0 (en)Pharmaceutical Formulation
GB0302435D0 (en)Pharmaceutical formulation
HK1089377A (en)Pharmaceutical composition
AU2003902322A0 (en)Pharmaceutical composition
HK1088245A (en)Pharmaceutical composition
HK1092702A (en)Pharmaceutical compositions
HK1092712A (en)Pharmaceutical compositions
[8]ページ先頭
©2009-2025 Movatter.jp